Search

everythinglearnresearchcommunity

for

Search:↓

The runner's bone injuries were linked to untreated Celiac Disease and low energy availability affecting her bone density.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Early hormones shape sex-specific differences in rat glands.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.